Agios Pharmaceuticals (AGIO) Non Operating Income (2021 - 2025)
Historic Non Operating Income for Agios Pharmaceuticals (AGIO) over the last 5 years, with Q3 2025 value amounting to $67000.0.
- Agios Pharmaceuticals' Non Operating Income fell 9594.19% to $67000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 4730.12%. This contributed to the annual value of $6.5 million for FY2024, which is 713.46% up from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' Non Operating Income is $67000.0, which was down 9594.19% from $523000.0 recorded in Q2 2025.
- Agios Pharmaceuticals' Non Operating Income's 5-year high stood at $6.5 million during Q2 2021, with a 5-year trough of $67000.0 in Q3 2025.
- Over the past 5 years, Agios Pharmaceuticals' median Non Operating Income value was $1.6 million (recorded in 2024), while the average stood at $2.0 million.
- In the last 5 years, Agios Pharmaceuticals' Non Operating Income skyrocketed by 3781.3% in 2024 and then crashed by 9594.19% in 2025.
- Agios Pharmaceuticals' Non Operating Income (Quarter) stood at $3.3 million in 2021, then plummeted by 58.48% to $1.4 million in 2022, then grew by 26.23% to $1.7 million in 2023, then fell by 5.25% to $1.6 million in 2024, then plummeted by 95.87% to $67000.0 in 2025.
- Its Non Operating Income was $67000.0 in Q3 2025, compared to $523000.0 in Q2 2025 and $1.3 million in Q1 2025.